Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-068450
Filing Date
2005-04-01
Accepted
2005-04-01 17:14:32
Documents
19
Period of Report
2005-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 804457
2 EXHIBIT 10.4 dex104.htm EX-10.4 26857
3 EXHIBIT 10.5 dex105.htm EX-10.5 47560
4 EXHIBIT 10.6.1 dex1061.htm EX-10.6.1 16947
5 EXHIBIT 10.7.1 dex1071.htm EX-10.7.1 8013
6 EXHIBIT 10.13 dex1013.htm EX-10.13 622236
7 EXHIBIT 10.14 dex1014.htm EX-10.14 494056
8 EXHIBIT 21.1 dex211.htm EX-21.1 701
9 EXHIBIT 23.1 dex231.htm EX-23.1 2209
10 EXHIBIT 31.1 dex311.htm EX-31.1 9130
11 EXHIBIT 31.2 dex312.htm EX-31.2 9133
12 EXHIBIT 32.1 dex321.htm EX-32.1 3024
13 EXHIBIT 32.2 dex322.htm EX-32.2 3456
14 GRAPHIC g55291g09h62.jpg GRAPHIC 30037
15 GRAPHIC g55291g09k82.jpg GRAPHIC 28657
16 GRAPHIC g55291g48m62.jpg GRAPHIC 28673
17 GRAPHIC g55291g69v43.jpg GRAPHIC 29401
18 GRAPHIC g55291img_003.jpg GRAPHIC 41832
19 GRAPHIC g55291img_004.jpg GRAPHIC 25976
  Complete submission text file 0001193125-05-068450.txt   2235752
Mailing Address
Business Address 1881 GROVE AVENUE RADFORD VA 24141 5406337900
NEW RIVER PHARMACEUTICALS INC (Filer) CIK: 0001288379 (see all company filings)

EIN.: 541816479 | State of Incorp.: VA
Type: 10-K | Act: 34 | File No.: 000-50851 | Film No.: 05726527
SIC: 2834 Pharmaceutical Preparations